Kingsview Wealth Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15,293
Closed -$30K 1458
2026
Q1
$30K Buy
+15,293
New +$35.9K ﹤0.01% 1319
2022
Q1
Sell
-8,346
Closed -$273K 919
2021
Q4
$273K Buy
8,346
+2,730
+49% +$110K 0.01% 768
2021
Q3
$230K Buy
+5,616
New +$204K 0.01% 763

Other funds holding GDRX

Kingsview Wealth Management's GDRX Position: Q2 2026 in Review

Kingsview Wealth Management sold out of GoodRx Holdings (GDRX) in Q2 2026, closing a stake of 15,293 shares — an estimated $30K sold.

Kingsview Wealth Management first reported a position in GDRX in Q3 2021 and held it in 3 quarters. The position peaked at $273K in Q4 2021. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Kingsview Wealth Management reported no remaining GoodRx Holdings position as of Q2 2026 after selling out during the quarter.
  • Kingsview Wealth Management sold 15,293 GoodRx Holdings shares in Q2 2026, an estimated $30K.
  • Kingsview Wealth Management first reported a position in GoodRx Holdings in Q3 2021 and held it in 3 quarters.
  • Kingsview Wealth Management's GoodRx Holdings position peaked at $273K in Q4 2021.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Kingsview Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.